Observations on patents and other IP from a dual-licensed practitioner
The letter below came to my attention recently. It was sent out by two professors in administrative positions at one of Israel’s institution of higher education. Can you spot the…
In the previous blog post I discussed the recent decision of the Israel High Court of Justice, which clarified that employee-inventors are not necessarily due compensation for their inventions, that…
The Israel Patent Statute includes a few sections (131-136) dealing with inventions invented by employees. Section 132 establishes a default setting whereby an invention made by an employee during the…
One of the difficulties with patent examination is that it can take a long time. If, as an applicant, you’re not in rush, that’s fine. But sometimes you don’t want…
This is the third installment discussing a situation in which patent practitioner X listed himself as an inventor on an application he drafted and filed on behalf of Z, assigned…
Yesterday I wrote about an interesting situation: patent practitioner X listed himself as an inventor on an application he drafted and filed on behalf of Z, and assigned all his…
This is the first of several posts about an interesting situation. X is a patent practitioner here in Israel. He’s a very smart guy, and he’s one of the straightest…
The hottest story in Israeli biotech in 2017 was the August acquisition of Kite Pharma by Gilead Sciences for 11.9 billion dollars, and the announcement in October of FDA approval…
I don’t think any readers of this blog have been living in a cave for the last 25+ years, but if you have, one of the most popular comic strips…
A few months ago, a story broke about a secret program at the USPTO, the “Sensitive Application Warning System”. The upshot was that the USPTO had a program under which…
I’m Dan Feigelson. I’ve been practicing patent law for over 30 years. I’m also opinionated, as you may discover in reading my writings here.